scholarly article | Q13442814 |
P50 | author | Paolo Cravedi | Q63926440 |
Samira Farouk | Q90255862 | ||
Barbara T. Murphy | Q107447951 | ||
P2093 | author name string | Lorenzo Gallon | |
Weijia Zhang | |||
Stephen I Alexander | |||
Zeguo Sun | |||
Philip J O'Connell | |||
Arjang Djamali | |||
Chengguo Wei | |||
Rex Neal Smith | |||
Nader Najafian | |||
Milagros D Samaniego | |||
Madhav C Menon | |||
Ivy A Rosales | |||
Zhengzi Yi | |||
Robert Colvin | |||
Caixia Xi | |||
Christopher Woytovich | |||
Karen L Keung | |||
Ciara Magee | |||
P2860 | cites work | The prevalence and meaning of fatigue in rheumatic disease. | Q54349156 |
Risk factors associated with post–kidney transplant malignancies: an article from the Cancer-Kidney International Network. | Q55266341 | ||
Pretransplant Donor-Specific HLA Class-I and -II Antibodies Are Associated With an Increased Risk for Kidney Graft Failure | Q60182181 | ||
HLA-DR and -DQ Eplet Mismatches and Transplant Glomerulopathy: A Nested Case-Control Study | Q63244396 | ||
Lack of NK cells in lupus patients with renal involvement | Q73978594 | ||
Cutting edge: molecular portrait of human autoimmune disease | Q74334835 | ||
Kidney allograft inflammation and fibrosis, causes and consequences | Q83183932 | ||
Assessing the risk of infection and rejection in Hispanic renal transplant recipients by means of an adenosine triphosphate release assay | Q83220179 | ||
The Synergistic Effect of Class II HLA Epitope-Mismatch and Nonadherence on Acute Rejection and Graft Survival | Q85416788 | ||
Pre-transplant immune state defined by serum markers and alloreactivity predicts acute rejection after living donor kidney transplantation | Q88083700 | ||
Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 | ||
limma powers differential expression analyses for RNA-sequencing and microarray studies | Q29617988 | ||
CD8(+)NKT-like cells regulate the immune response by killing antigen-bearing DCs. | Q30664500 | ||
Observational support for an immunoregulatory role of CD3+CD4+CD25+IFN-gamma+ blood lymphocytes in kidney transplant recipients with good long-term graft outcome | Q33321031 | ||
The Immunological Genome Project: networks of gene expression in immune cells. | Q34830433 | ||
The impact of acute rejection in kidney transplantation on long-term allograft and patient outcome | Q35089879 | ||
Late kidney allograft loss: what we know about it, and what we can do about it | Q35153318 | ||
Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts | Q35790552 | ||
Loss of CD28 on Peripheral T Cells Decreases the Risk for Early Acute Rejection after Kidney Transplantation | Q35948016 | ||
Immune Profiles to Predict Response to Desensitization Therapy in Highly HLA-Sensitized Kidney Transplant Candidates | Q35990094 | ||
Risk factors for graft loss and mortality after renal transplantation according to recipient age: a prospective multicentre study | Q36479764 | ||
Robust enumeration of cell subsets from tissue expression profiles | Q36539395 | ||
Kidney transplantation as primary therapy for end-stage renal disease: a National Kidney Foundation/Kidney Disease Outcomes Quality Initiative (NKF/KDOQITM) conference | Q36666806 | ||
Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs | Q37692292 | ||
Natural killer cells in human autoimmune diseases | Q37805560 | ||
Gene expression profiles in peripheral blood for the diagnosis of autoimmune diseases | Q37851230 | ||
Gene expression profiling in breast cancer: classification, prognostication, and prediction | Q37958156 | ||
The molecular phenotypes of rejection in kidney transplant biopsies. | Q38461250 | ||
Looking into the Graft without a Biopsy: Biomarkers of Acute Rejection in Renal Transplantation. | Q38680129 | ||
Immune Exhaustion and Transplantation | Q38686551 | ||
Moving Biomarkers toward Clinical Implementation in Kidney Transplantation | Q38773711 | ||
Chronic allograft injury: Mechanisms and potential treatment targets | Q39009557 | ||
Prolonged Ischemic Time, Delayed Graft Function, and Graft and Patient Outcomes in Live Donor Kidney Transplant Recipients. | Q39869963 | ||
Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
Biopsy transcriptome expression profiling to identify kidney transplants at risk of chronic injury: a multicentre, prospective study | Q41035928 | ||
The natural history of chronic allograft nephropathy | Q44688416 | ||
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions | Q45342440 | ||
Complement-binding anti-HLA antibodies and kidney-allograft survival | Q46141053 | ||
Kidney allograft survival after acute rejection, the value of follow-up biopsies | Q46211382 | ||
Comprehensive analysis of long non-coding RNA and mRNA expression profiles in rheumatoid arthritis | Q47149296 | ||
Relationship between pre-transplant physical function and outcomes after kidney transplant | Q48124762 | ||
Mechanistic Sharing Between NK Cells in ABMR and Effector T Cells in TCMR. | Q48217077 | ||
Late graft failure after kidney transplantation as the consequence of late versus early events. | Q50005462 | ||
Which is more nephrotoxic for kidney transplants: BK nephropathy or rejection? | Q50067987 | ||
The Value of Protocol Biopsies to Identify Patients With De Novo Donor-Specific Antibody at High Risk for Allograft Loss. | Q51010023 | ||
Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes. | Q51775005 | ||
Panel of reactive T cells as a measurement of primed cellular alloimmunity in kidney transplant candidates. | Q51826320 | ||
Pathologic characteristics of early or late acute cellular rejection and outcome after kidney transplant. | Q52874780 | ||
P433 | issue | 11 | |
P577 | publication date | 2019-06-06 | |
P1433 | published in | JCI insight | Q27727187 |
P1476 | title | Pretransplant transcriptomic signature in peripheral blood predicts early acute rejection | |
P478 | volume | 4 |
Search more.